Trade

Meet our team at ASGCT 2024! We invite you to visit our booth (#716) May 7-11 to learn about our complete iPSC platform and new cell manufacturing capabilities. We look forward to discussing your projects.

Where: Baltimore, MD l Booth # 716
When: May 7-11, 2024
Link: https://annualmeeting.asgct.org/

About Applied StemCell, Inc.

ASC has a Drug Manufacturing License from the California Department of Public Health, Food and Drug Branch (FDB). It has a Quality Management System (ISO 13485 certified) and established cGMP-compliant protocols for cell banking and manufacturing, iPSC generation, genome editing, iPSC differentiation, and cell product manufacturing. With over 15 years of gene-editing and stem cell expertise, ASC offers comprehensive and customized cell and gene CRO/CDMO solutions. Its core iPSC and genome editing (CRISPR and TARGATT^TM) technologies, facilitate site-specific, large cargo (up to 20kb) transgene integration and the development of allogenic cell products.

Media Contact:
Maki Ogawa
Marketing Director, Applied StemCell, Inc.
408-773-8007
[email protected]

Join the ASC team at ISCT 2024! We invite you to visit our booth (#727) May 29 – June 1 to learn about our end-to-end iPSC solutions platform and new cell manufacturing capabilities. We look forward to discussing your projects.

Where: Vancouver, Canada l Booth #727
When: May 29 – June 1, 2024
Link: https://www.isctglobal.org/isct2024/home

Applied StemCell’s Global Showcase
When: Thursday, May 30, 18:00-18:15 (6:00 PM – 6:15 PM)
Speaker: Ruby Yanru Chen-Tsai, Ph.D., CEO, Founder, and President

About Applied StemCell, Inc.

ASC has a Drug Manufacturing License from the California Department of Public Health, Food and Drug Branch (FDB). It has a Quality Management System (ISO 13485 certified) and established cGMP-compliant protocols for cell banking and manufacturing, iPSC generation, genome editing, iPSC differentiation, and cell product manufacturing. With over 15 years of gene-editing and stem cell expertise, ASC offers comprehensive and customized cell and gene CRO/CDMO solutions. Its core iPSC and genome editing (CRISPR and TARGATT^TM) technologies, facilitate site-specific, large cargo (up to 20kb) transgene integration and the development of allogenic cell products.

Media Contact:
Maki Ogawa
Marketing Director, Applied StemCell, Inc.
408-773-8007
[email protected]

Join the ASC team at The BIO International Convention 2024! We invite you to visit us June 3 – June 6.

Where: San Diego, California
When: June 3 – June 6, 2024
Link: https://www.isctglobal.org/isct2024/home

About Applied StemCell, Inc.

ASC has a Drug Manufacturing License from the California Department of Public Health, Food and Drug Branch (FDB). It has a Quality Management System (ISO 13485 certified) and established cGMP-compliant protocols for cell banking and manufacturing, iPSC generation, genome editing, iPSC differentiation, and cell product manufacturing. With over 15 years of gene-editing and stem cell expertise, ASC offers comprehensive and customized cell and gene CRO/CDMO solutions. Its core iPSC and genome editing (CRISPR and TARGATT^TM) technologies, facilitate site-specific, large cargo (up to 20kb) transgene integration and the development of allogenic cell products.

Media Contact:
Maki Ogawa
Marketing Director, Applied StemCell, Inc.
408-773-8007
[email protected]